628737-15-5 = 802904-66-1 反应条件:1.1 Reagents: Triethylamine Solvents: Dichloromethane2.1 Reagents: Sodium Hydroxide Solvents: Tetrahydrofuran,Water 标题:Substituted Indole-1-Acetic Acids As Potent And Selective Crth2 Antagonists-Discovery Of Azd1981 作者:Luker,Tim; Et Al 参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2011 卷标:21(21) 页码:6288-6292]
646515-19-7 = 802904-66-1 反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Tetrahydrofuran,Water 标题:Substituted Indole-1-Acetic Acids As Potent And Selective Crth2 Antagonists-Discovery Of Azd1981 作者:Luker,Tim; Et Al 参考文献:Bioorganic & Medicinal Chemistry Letters 日期:2011 卷标:21(21) 页码:6288-6292]
628737-12-2 + 105-36-2 = 802904-66-1 反应条件:1.1 Reagents: Sodium Hydride Solvents: Tetrahydrofuran1.2 Reagents: Hydrogen Catalysts: Platinum Solvents: Ethyl Acetate1.3 Reagents: Triethylamine Solvents: Dichloromethane1.4 Reagents: Ethanol,Sodium Hydroxide,Water1.5 Reagents: Hydrochloric Acid Solvents: Methyl Isobutyl Ketone 标题:Route Design,The Foundation Of Successful Chemical Development 作者:Cornwall,Philip; Et Al 参考文献:Bioorganic & Medicinal Chemistry 日期:2018 卷标:26(14) 页码:4336-4347]
628737-13-3 = 802904-66-1 反应条件:1.1 Reagents: Hydrogen Catalysts: Platinum Solvents: Ethanol1.2 Reagents: Triethylamine Solvents: Dichloromethane1.3 Reagents: Sodium Hydroxide Solvents: Tetrahydrofuran 标题:Route Design,The Foundation Of Successful Chemical Development 作者:Cornwall,Philip; Et Al 参考文献:Bioorganic & Medicinal Chemistry 日期:2018 卷标:26(14) 页码:4336-4347]
628737-12-2 + 105-36-2 = 802904-66-1 反应条件:1.1 Reagents: Sodium Hydride Solvents: Tetrahydrofuran2.1 Reagents: Hydrogen Catalysts: Platinum Solvents: Ethanol2.2 Reagents: Triethylamine Solvents: Dichloromethane2.3 Reagents: Sodium Hydroxide Solvents: Tetrahydrofuran 标题:Route Design,The Foundation Of Successful Chemical Development 作者:Cornwall,Philip; Et Al 参考文献:Bioorganic & Medicinal Chemistry 日期:2018 卷标:26(14) 页码:4336-4347]
1260673-30-0 = 802904-66-1 反应条件:1.1 Reagents: Acetic Acid,Sodium Iodide Solvents: Xylene2.1 Reagents: Sodium Hydroxide Solvents: Ethanol,Water 标题:Route Design,The Foundation Of Successful Chemical Development 作者:Cornwall,Philip; Et Al 参考文献:Bioorganic & Medicinal Chemistry 日期:2018 卷标:26(14) 页码:4336-4347]
1260673-29-7 = 802904-66-1 反应条件:1.1 -2.1 -3.1 -4.1 Reagents: Sodium Hydroxide Solvents: Ethanol,Water 标题:Route Design,The Foundation Of Successful Chemical Development 作者:Cornwall,Philip; Et Al 参考文献:Bioorganic & Medicinal Chemistry 日期:2018 卷标:26(14) 页码:4336-4347
📜4,4'-二氯二苯二硫醚置于四丁基碘化铵 水,Sodium Hydroxide体系中,用 乙醇,Xylene 作为反应溶剂,化学反应 3.67H,反应生成 4-(乙酰氨基)-3-[(4-氯苯基)硫代]-2-甲基-1H-吲哚-1-乙酸 参考文献: Intermediates And Processes For The Preparation Of 4-(Acetylamino))-3-[(4-Chloro-Phenyl) Thio]-2-Methyl-1H-Indole-1-Acetic Acid[fr] Intermédiaires Et Procédés Pour La Préparation D'Acide 4-(Acétylamino)-3-[(4-Chloro-Phényl)Thio]-2-Méthyl-1H-Indole-1-Acétique 标题: Intermediates And Processes For The Preparation Of 4-(Acetylamino))-3-[(4-Chloro-Phenyl) Thio]-2-Methyl-1H-Indole-1-Acetic Acid[fr] Intermédiaires Et Procédés Pour La Préparation D'Acide 4-(Acétylamino)-3-[(4-Chloro-Phényl)Thio]-2-Méthyl-1H-Indole-1-Acétique 摘要:这项发明涉及公式(x)的化合物及其盐,以及它们作为公式(i)的药物化合物合成改进制造过程中的中间体的用途:X为=0,=n-0H或=n-oc(o)me;y为氢,Phs-或对氯苯硫基;z为氢或-Ch2Coor1,其中r1从氢,可选择取代的烃基和可选择取代的杂环烷基中选择.
专利号:US-8227622-B2 优先权日:2009-07-06 标题:Pharmaceutical process and intermediates 714 发明人:AINGE DEBRA; MERIFIELD ERIC; THOMSON COLIN; BUTTERS MICHAEL; RAMAKRISHNAN RAVI; RAYAPATI RAVI NAIDU; SHARMA PARHALAD RAY 权利人:AINGE DEBRA; MERIFIELD ERIC; THOMSON COLIN; BUTTERS MICHAEL; RAMAKRISHNAN RAVI; RAYAPATI RAVI NAIDU; SHARMA PARHALAD RAY; ASTRAZENECA AB 摘要:The invention relates to compounds of formula (X), and salts thereof, and their use as intermediates in improved manufacturing processes for the synthesis of pharmaceutical compound (I): n n n n n n n n n n X is â• O, â• N—OH or â• N—OC(O)Me; Y is hydrogen, PhS- or p-chlorophenylsulfanyl; Z is hydrogen or —CH 2 COOR 1 wherein R 1 is selected from hydrogen, optionally substituted hydrocarbyl and optionally substituted heterocyclyl.
1: Snell N, Foster M, Vestbo J. Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD. Respir Med. 2013 Nov;107(11):1722-30. doi: 10.1016/j.rmed.2013.06.006. Epub 2013 Jul 1. doi: 10.1111/bph.12053. 3: Luker T, Bonnert R, Brough S, Cook AR, Dickinson MR, Dougall I, Logan C, Mohammed RT, Paine S, Sanganee HJ, Sargent C, Schmidt JA, Teague S, Thom S. Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6288-92. doi: 10.1016/j.bmcl.2011.08.124. Epub 2011 Sep 5.
合成参考文献
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198